These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 17408374

  • 1. Use of viral vectors for the development of vaccines.
    Liniger M, Zuniga A, Naim HY.
    Expert Rev Vaccines; 2007 Apr; 6(2):255-66. PubMed ID: 17408374
    [Abstract] [Full Text] [Related]

  • 2. Applications and challenges of multivalent recombinant vaccines.
    Naim HY.
    Hum Vaccin Immunother; 2013 Mar; 9(3):457-61. PubMed ID: 23249651
    [Abstract] [Full Text] [Related]

  • 3. Viral vectors for malaria vaccine development.
    Li S, Locke E, Bruder J, Clarke D, Doolan DL, Havenga MJ, Hill AV, Liljestrom P, Monath TP, Naim HY, Ockenhouse C, Tang DC, Van Kampen KR, Viret JF, Zavala F, Dubovsky F.
    Vaccine; 2007 Mar 30; 25(14):2567-74. PubMed ID: 16914237
    [Abstract] [Full Text] [Related]

  • 4. Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens.
    Gómez CE, Nájera JL, Sánchez R, Jiménez V, Esteban M.
    Vaccine; 2009 May 21; 27(24):3165-74. PubMed ID: 19446187
    [Abstract] [Full Text] [Related]

  • 5. Recombinant viruses as vaccines against viral diseases.
    Souza AP, Haut L, Reyes-Sandoval A, Pinto AR.
    Braz J Med Biol Res; 2005 Apr 21; 38(4):509-22. PubMed ID: 15962176
    [Abstract] [Full Text] [Related]

  • 6. Alphavirus-based vaccines.
    Lundstrom K.
    Curr Opin Mol Ther; 2002 Feb 21; 4(1):28-34. PubMed ID: 11883692
    [Abstract] [Full Text] [Related]

  • 7. Viral vectors as potential HIV-1 vaccines.
    Schnell MJ.
    FEMS Microbiol Lett; 2001 Jun 25; 200(2):123-9. PubMed ID: 11425463
    [Abstract] [Full Text] [Related]

  • 8. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C, Rogers WO, Gowda K, Doolan DL.
    Immunol Lett; 2007 Aug 15; 111(2):92-102. PubMed ID: 17604849
    [Abstract] [Full Text] [Related]

  • 9. Viral vectors in malaria vaccine development.
    Limbach KJ, Richie TL.
    Parasite Immunol; 2009 Sep 15; 31(9):501-19. PubMed ID: 19691555
    [Abstract] [Full Text] [Related]

  • 10. Recombinant viral vectors: cancer vaccines.
    Harrop R, John J, Carroll MW.
    Adv Drug Deliv Rev; 2006 Oct 01; 58(8):931-47. PubMed ID: 17030074
    [Abstract] [Full Text] [Related]

  • 11. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S, Feng X, Shu T, Matano T, Hasegawa M, Wang X, Ma H, Li H, Li Z, Zeng Y.
    Vaccine; 2008 Nov 11; 26(48):6124-31. PubMed ID: 18812199
    [Abstract] [Full Text] [Related]

  • 12. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
    Anderson RJ, Schneider J.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B24-34. PubMed ID: 17698262
    [Abstract] [Full Text] [Related]

  • 13. Recombinant DNA virus vectors for vaccination.
    Moss B.
    Semin Immunol; 1990 Sep 27; 2(5):317-27. PubMed ID: 2134016
    [Abstract] [Full Text] [Related]

  • 14. Rational design of gene-based vaccines.
    Barouch DH.
    J Pathol; 2006 Jan 27; 208(2):283-9. PubMed ID: 16362986
    [Abstract] [Full Text] [Related]

  • 15. Use of attenuated bacteria as delivery vectors for DNA vaccines.
    Daudel D, Weidinger G, Spreng S.
    Expert Rev Vaccines; 2007 Feb 27; 6(1):97-110. PubMed ID: 17280482
    [Abstract] [Full Text] [Related]

  • 16. The prospective preventative HIV vaccine based on modified poliovirus.
    Zhang YD, Lu XL, Li NF.
    Med Hypotheses; 2007 Feb 27; 68(6):1258-61. PubMed ID: 17196342
    [Abstract] [Full Text] [Related]

  • 17. The potential role of fowlpox virus in rational vaccine design.
    Beukema EL, Brown MP, Hayball JD.
    Expert Rev Vaccines; 2006 Aug 27; 5(4):565-77. PubMed ID: 16989636
    [Abstract] [Full Text] [Related]

  • 18. Gene therapy with poxvirus vectors.
    Moroziewicz D, Kaufman HL.
    Curr Opin Mol Ther; 2005 Aug 27; 7(4):317-25. PubMed ID: 16121697
    [Abstract] [Full Text] [Related]

  • 19. DNA vaccines: vector design, delivery, and antigen presentation.
    Feltquate DM.
    J Cell Biochem Suppl; 1998 Aug 27; 30-31():304-11. PubMed ID: 9893284
    [Abstract] [Full Text] [Related]

  • 20. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine.
    Wingard JB, Anderson B, Weissman D.
    Eur J Immunol; 2008 May 27; 38(5):1310-20. PubMed ID: 18412164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.